-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Tilray Isn’t Your Cannabis Bet for the Long-Haul
Despite some positives, TLRY stock still has plenty to do before it can come close to achieving its $4 billion revenue target by 2024.
Tilray Stock Dropped, But it Still Has Most of its Growth Priced in
TLRY stock doesn't appear to have the wherewithal to achieve its seemingly insurmountable revenue growth targets.
Sundial Stock Is a Buying Opportunity Thanks to Tax Loss Season
SNDL stock moved sharply lower in recent weeks despite positive news. Here's why Sundial dropped and what will change its fortunes in 2022.
Tilray Stock May Rally in January
Marijuana stocks have plunged once again, making TLRY stock a buy-the-dip candidate. Beware of the company's poor fundamentals, however.
Sundial Growers Has More Than One Way Back to Higher Prices
With its M&A and investments yet another sign it's making the right moves, SNDL stock is looking more promising.
Don’t Bet on Sundial Growers Achieving the American Dream
If you’re thinking about the ever-popular SNDL stock, you should focus your due diligence on the Canadian market exclusively.
Orally Administered Covid-19 Treatment Should Bolster Merck’s Value
MRK stock can have a place in just about any safety-focused biopharmaceutical portfolio as the stock offers dividends at a good value.
Cassava Sciences Just Returned to the Buy Zone
There's no need to panic about SAVA stock, as Cassava Sciences just launched an important study focused on treating Alzheimer's disease.
Sundial Growers Is Too Dependent Upon U.S. Legalization to Bet on Yet
Shares of the Canadian marijuana producer have a three-month return of negative 16.6%, but SNDL stock is not out of the woods yet.
Cannabis Stocks: How One Analyst Just Snuffed Out TLRY, CRON, CGC Stocks
Barclays has issued a report that has cast doubt over an entire industry and has sent cannabis stocks plunging. Should you be worried?
Tilray Is Creeping Into the U.S., But Its Sales Goal May Lead to Dilution
Tilray is slowly moving into the U.S. but it may soon face dilution. TLRY stock could fall if shares are issued to reach a revenue goal.
4 New Patents Add to Progenity’s Appeal
PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress.
Tilray Has More Bad News Harshing Their Mellow
But despite the near constant bad news for the cannabis industry, aggressive investors should still buy TLRY stock under $11.
Sundial Growers Stock Can’t Buy Its Way Into Long-Term Profitability
Cannabis stocks were one of the first groups of meme stocks in the latest leg of this bull market as SNDL stock shows, FOMO can be a risk.
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here
Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.
